ascomp with codeine
Generic: butalbital, aspirin, cafeine, and codeine phosphate
Labeler: lgm pharma solutions, llcDrug Facts
Product Profile
Brand Name
ascomp with codeine
Generic Name
butalbital, aspirin, cafeine, and codeine phosphate
Labeler
lgm pharma solutions, llc
Dosage Form
CAPSULE
Routes
Active Ingredients
aspirin 325 mg/1, butalbital 50 mg/1, caffeine 40 mg/1, codeine phosphate 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
79739-6094
Product ID
79739-6094_8e0b0c51-eba5-42d6-99d3-7623753e3985
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075231
DEA Schedule
ciii
Listing Expiration
2027-12-31
Marketing Start
2001-11-30
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
797396094
Hyphenated Format
79739-6094
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ascomp with codeine (source: ndc)
Generic Name
butalbital, aspirin, cafeine, and codeine phosphate (source: ndc)
Application Number
ANDA075231 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 325 mg/1
- 50 mg/1
- 40 mg/1
- 30 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (79739-6094-1)
Packages (1)
Ingredients (4)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8e0b0c51-eba5-42d6-99d3-7623753e3985", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175693", "M0002177", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["R16CO5Y76E", "KHS0AZ4JVK", "3G6A5W338E", "GSL05Y1MN6"], "rxcui": ["994237", "994239"], "spl_set_id": ["1cab3106-1064-4b42-892b-39f405d9e02f"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Barbiturates [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Barbiturate [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["LGM PHARMA SOLUTIONS, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (79739-6094-1)", "package_ndc": "79739-6094-1", "marketing_start_date": "20200724"}], "brand_name": "Ascomp with Codeine", "product_id": "79739-6094_8e0b0c51-eba5-42d6-99d3-7623753e3985", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Barbiturate [EPC]", "Barbiturates [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Full Opioid Agonists [MoA]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Opioid Agonist [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "79739-6094", "dea_schedule": "CIII", "generic_name": "Butalbital, Aspirin, Cafeine, and Codeine Phosphate", "labeler_name": "LGM PHARMA SOLUTIONS, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ascomp with Codeine", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "BUTALBITAL", "strength": "50 mg/1"}, {"name": "CAFFEINE", "strength": "40 mg/1"}, {"name": "CODEINE PHOSPHATE", "strength": "30 mg/1"}], "application_number": "ANDA075231", "marketing_category": "ANDA", "marketing_start_date": "20011130", "listing_expiration_date": "20271231"}